TORONTO--(BUSINESS WIRE)--Today, RioCan Real Estate Investment Trust ("RioCan†or the "Trust†) (TSX: REI.UN) is hosting its 2025 Investor Day to share its strategic priorities and provide a three-year financial outlook for 2026 to 2028. Strategic Priorities "RioCan's strategy is anchored in the strength of our core retail platform and our commitment to durable growth,†said Jonathan Gitlin, President and Chief Executive Officer. "Fueled by our strong retail portfolio where Canadians shop every. ...

Financial Data and Key Metrics Changes - Cash collections grew 14% year-over-year to $542 million, reflecting strong recent purchases and operational initiatives [5][18] - Adjusted EBITDA for the last 12 months increased 15% to $1.3 billion, indicating operational leverage [6][26] - The net loss was $408 million for the quarter, but adjusted net income was $21 million, translating to an adjusted ROATE of 9% [6][25] Business Line Data and Key Metrics Changes - Portfolio purchases totaled $255 million, with 60% in the Americas and 40% in Europe, reflecting a more selective investment approach [16] - U.S. legal cash collections increased by 27% year-over-year to $125 million, driven by improvements in the legal collections channel [5][19] - Portfolio revenue for the quarter rose 12% year-over-year to $310 million, with portfolio income growing 20% to $259 million [20] Market Data and Key Metrics Changes - Cash collections in Europe exceeded expectations by 10%, with strong performance across core markets [19] - The Americas saw cash collections exceed expectations by 6%, with U.S. legal collections representing 46% of cash collected in Americas Core [19][30] - ERC at quarter-end was $8.4 billion, up 15% year-over-year and 1% sequentially [17] Company Strategy and Development Direction - The company is focused on cost efficiency, having implemented a cost reduction program that is expected to yield $20 million in annualized savings [8][31] - A new organizational structure in U.S. operations aims to enhance accountability and decision-making [9] - The establishment of a second talent hub in Charlotte, North Carolina, is intended to attract specialized talent [10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the underlying European business performance, despite the goodwill impairment charge [6][23] - The company is monitoring the consumer environment, particularly in the U.S., but believes its global diversification mitigates risks [29] - The company reaffirmed its financial targets for 2025, including a purchase target of $1.2 billion and cash collections growth in the high single digits [30] Other Important Information - A non-recurring non-cash goodwill impairment charge of $413 million was recorded, primarily due to a decline in stock price [5][23] - The company issued its first euro-denominated bond, raising EUR 300 million to pay down bank debt [28] Q&A Session Summary Question: Clarification on the $15 million payment - Management indicated that the $15 million payment was a unique situation and not expected to recur frequently [33][34] Question: Insights on consumer health in the U.S. - Management noted that the overall customer profile remains stable despite recent headlines about consumer bifurcation [36] Question: Timeline for achieving GAAP profitability from portfolio income - Management acknowledged the ongoing journey towards profitability and indicated that operational improvements could lead to higher future expectations [36][37] Question: Impact of goodwill charge on financial performance - Management clarified that the goodwill charge was a non-cash adjustment and did not affect operational performance or ERC [45][46] Question: Guidance for collections growth in Q4 - Management confirmed that while Q4 typically sees lower growth, they remain confident in achieving their annual targets [48]

Financial Data and Key Metrics Changes - Bausch Health reported a year-over-year revenue growth of 7% on a reported basis and 5% on an organic basis, achieving $2.681 billion in revenue for the third quarter [4][8] - Adjusted EBITDA increased by 8% year-over-year to $986 million, with an adjusted gross margin of 72.7%, which is 40 basis points lower than the previous year [8][9] - The company reduced its debt by approximately $600 million, leading to an increase in full-year guidance for revenue, adjusted EBITDA, and adjusted operating cash flow [5][15] Business Line Data and Key Metrics Changes - The Solta Medical segment saw a remarkable 25% growth on a reported basis and 24% on an organic basis, while Salix delivered 12% growth on a reported basis and 11% on an organic basis [6][10] - Xifaxan revenue grew 16% in the third quarter, with volume up 9%, driven by strong performance in the hepatology segment [10][20] - The diversified segment experienced a revenue decrease of 4% on a reported basis and 6% on an organic basis, primarily due to challenges in the neurology business [13][14] Market Data and Key Metrics Changes - International segment revenues decreased by 2% on a reported basis and 4% on an organic basis, with mixed performance across geographies [11] - EMEA led the international segment with a 12% increase, while Canada and LATAM contracted by 8% and 17%, respectively [11] - The Asia-Pacific region contributed significantly to Solta Medical's growth, with South Korea achieving 96% growth year-over-year [12][22] Company Strategy and Development Direction - The company is focused on five strategic priorities: people, growth, efficiency, innovation, and unlocking value, which guide its vision for the future [18] - Bausch Health aims to enhance its operational assets and continue executing its innovation and profitable growth agenda [16][18] - The acquisition of DURECT Corporation is expected to complement the existing portfolio and enhance the R&D pipeline, particularly in hepatology [24][25] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating a dynamic macro backdrop and highlighted strong operational performance [5][18] - The company anticipates continued growth in its key segments, particularly in Xifaxan and Solta Medical, while also preparing for the impact of CMS pricing negotiations [19][33] - Full-year guidance has been raised, reflecting positive trends across the portfolio, with revenue expected between $5 billion and $5.1 billion [15][16] Other Important Information - The company exited the 340B program and Medicaid drug rebate program to optimize sales channels and enhance patient assistance programs [61][62] - The focus remains on deleveraging the business and optimizing the capital structure, with plans to use free cash flow for debt servicing [66][68] Q&A Session Summary Question: Revenue growth for Xifaxan outpacing script growth - Management explained that the disconnect is due to a one-time benefit associated with gross-to-net accrual and strong new patient starts [30][32] Question: Dynamics of CMS pricing negotiations - Management confirmed ongoing fruitful negotiations with CMS and expects pricing to be published on November 30, 2025 [33][34] Question: Revised guidance and one-time factors - Management acknowledged one-time adjustments in Q3 but emphasized positive trends across the portfolio [40][41] Question: SG&A spending and future run rates - Management indicated that Q3 SG&A was unusually low due to non-recurring accrual changes, suggesting Q1 and Q2 as better indicators for future spending [42][43] Question: RED-C phase 3 results timeline - Management confirmed that both phase 3 studies will have a combined readout in early 2026, which will be the final readout for the program [45][46] Question: Impact of exiting the 340B program - Management highlighted the decision was made to optimize sales channels and enhance patient assistance programs [62][63] Question: Debt refinancing and deleveraging strategies - Management outlined plans to use free cash flow for debt servicing and mentioned potential asset sales as a means to support deleveraging [66][68]

Financial Data and Key Metrics Changes - Gentherm reported record quarterly revenue of $387 million, an increase of 4.1% year-over-year, with revenues excluding foreign currency translation increasing by 2.4% [15][16] - Adjusted EBITDA was $49 million, representing 12.7% of sales, a slight decline from 12.9% in the same quarter last year due to higher material costs and operating expenses [16] - Year-to-date operating cash flow reached $88 million, with net leverage at 0.2x, indicating strong financial health and access to capital [16][17] Business Line Data and Key Metrics Changes - Automotive climate and comfort solutions revenue increased by 8.6% year-over-year, or 7% excluding foreign exchange impacts, offsetting planned revenue decreases from strategic exits [16] - Medical revenue decreased by 0.4% year-over-year, or 1.6% excluding foreign exchange [16] Market Data and Key Metrics Changes - Third quarter automotive new business awards totaled $745 million, bringing the year-to-date total to $1.8 billion, with expectations to exceed $2 billion for the full year [4][11] - Improved performance was noted in China, with several new programs launched with domestic OEMs contributing to growth [5][14] Company Strategy and Development Direction - The company is focused on scaling core technologies across multiple end markets to drive profitable growth, with a commercial funnel of over $300 million in lifetime revenue opportunities [8][10] - Gentherm is actively pursuing M&A opportunities to access new markets and expand its product portfolio, aligning with its core technology platforms [10][50] Management's Comments on Operating Environment and Future Outlook - Management acknowledged potential impacts from supply chain disruptions but emphasized ongoing efforts to mitigate risks and maintain visibility [7][38] - The company is increasing the midpoint of its revenue guidance for the year, expecting revenue in the range of $1.47 billion to $1.49 billion, while narrowing the adjusted EBITDA margin range to 11.9% to 12.3% [17][18] Other Important Information - Gentherm is preparing for production in the furniture market, with expectations to start in Q1 of 2026, utilizing existing capacity [8][30] - The company is also focusing on the medical sector, with a significant product announcement anticipated near year-end [9] Q&A Session Summary Question: Factors contributing to momentum in winning conquest business - Management highlighted innovative solutions, strong customer relationships, and a value-added proposition as key factors driving success in securing new business [22][23] Question: Breakdown of the $300 million adjacent market opportunity - The pipeline is roughly divided into a third for furniture, a third for commercial vehicles, and a third for other mobility solutions, with furniture showing rapid adoption [25][26] Question: Near-term production environment and guidance - Management discussed ongoing supply chain issues, including impacts from Jaguar Land Rover and aluminum supply, but noted no significant schedule shifts yet [36][38] Question: Potential markets for adjacent opportunities - The company is evaluating the Indian market, particularly for two-wheelers, as a new growth opportunity [41] Question: Strategic footprint alignment plan and margin progression - Expected savings from the footprint transition will be more pronounced in 2027, with legacy costs falling off and inventory build impacting margins [47][48] Question: M&A strategy focus - M&A efforts will focus on building resilience, accessing new markets, and expanding product offerings, aligning with the company's core strategy [50]

Financial Data and Key Metrics Changes - Gentherm reported record quarterly revenue of $387 million, representing a 4.1% increase year-over-year, with revenues excluding foreign currency translation increasing by 2.4% [18][19] - Adjusted EBITDA was $49 million, or 12.7% of sales, compared to 12.9% in the same quarter last year, reflecting a 20 basis point decline primarily due to higher material costs [19] - Operating cash flow year-to-date reached $88 million, strengthening the company's balance sheet, with net leverage at 0.2 times at the end of the quarter [20] Business Line Data and Key Metrics Changes - Automotive Climate and Comfort Solutions revenue increased by 8.6% year-over-year, or 7% excluding foreign exchange impacts, which offset planned revenue decreases from strategic exits [19] - Medical revenue decreased by 0.4% year-over-year, or 1.6% excluding foreign exchange [19] Market Data and Key Metrics Changes - Third quarter automotive new business awards totaled $745 million, bringing the year-to-date total to $1.8 billion, with expectations to exceed $2 billion for the full year [6][14] - Improved performance was noted in China, with the automotive climate and comfort solutions outperforming actual light vehicle production in key markets by 160 basis points, excluding foreign exchange [7][16] Company Strategy and Development Direction - The company is focused on scaling core technologies across multiple end markets to drive profitable growth, with a commercial funnel of over $300 million in lifetime revenue generated in the last 90 days [10] - Gentherm is preparing to enter the furniture market, with production expected to start in 2026, leveraging existing plant capacity [10][11] - The company is also pursuing M&A opportunities to access new markets and expand its product portfolio, aligning with its core technology platforms [13][51] Management's Comments on Operating Environment and Future Outlook - Management expressed caution regarding potential supply chain impacts on OEM production but noted that they are actively working with customers and suppliers to mitigate risks [9][40] - The company increased the midpoint of its revenue guidance for the full year to a range of $1.47 billion to $1.49 billion, driven by improved light vehicle industry production expectations [21] Other Important Information - The company is in discussions with several furniture brands for thermal and pneumatic solutions, viewing this as an attractive adjacent market with significant annual volumes and margin profiles [11] - Gentherm's global strategic manufacturing footprint realignment plans are on track to be substantially complete by the end of next year, with significant progress in relocating manufacturing processes [13] Q&A Session Summary Question: Factors contributing to conquest business momentum - Management highlighted innovative solutions, strong commercial relationships with OEMs, and the value proposition provided to end users as key factors driving momentum in winning conquest business [26][28] Question: Breakdown of the $300 million adjacent market opportunity - Management indicated that the pipeline is roughly a third for furniture, a third for commercial vehicles, and a third for other mobility, with furniture showing rapid adoption and expected revenue starting in 2026 [30][32] Question: Near-term production environment and guidance - Management addressed concerns regarding supply chain issues, noting that while there are challenges, they have not seen significant impacts on schedules yet [39][42] Question: Opportunities in adjacent markets - Management discussed the Indian market as an attractive opportunity, particularly for two-wheelers, and emphasized the potential for alternative revenue streams [44][45] Question: Strategic footprint alignment plan and margin progression - Management expects to see incremental savings from the strategic footprint alignment plan, with real savings anticipated more in 2027 [47][48] Question: M&A pipeline focus - Management clarified that M&A efforts will focus on building a more resilient company, providing access to new markets, and broadening the product portfolio [50][51]

Financial Data and Key Metrics Changes - Gentherm reported record quarterly revenue of $387 million, an increase of 4.1% year-over-year, with revenues excluding foreign currency translation increasing by 2.4% [14][15] - Adjusted EBITDA was $49 million, representing 12.7% of sales, a slight decline from 12.9% in the same quarter last year due to higher material costs and operating expenses [15] - Operating cash flow year-to-date reached $88 million, with net leverage at 0.2 times, indicating strong financial health and access to capital [16] Business Line Data and Key Metrics Changes - Automotive climate and comfort solutions revenue increased by 8.6% year-over-year, or 7% excluding foreign exchange, offsetting planned revenue decreases from strategic exits [15] - Medical revenue decreased by 0.4% year-over-year, or 1.6% excluding foreign exchange, highlighting challenges in that segment [15] Market Data and Key Metrics Changes - The company secured $745 million in new automotive business awards in Q3, bringing the year-to-date total to $1.8 billion, on track to exceed $2 billion for the full year [4][10] - Improved performance was noted in China, with several new programs launched with domestic OEMs contributing to growth [5][12] Company Strategy and Development Direction - Gentherm is focused on scaling core technologies across multiple end markets to drive profitable growth, with significant progress in power sports and commercial vehicles [6][7] - The company is preparing to enter the furniture market, with a $300 million commercial funnel identified, indicating a strategic move into adjacent markets [7][25] - M&A is viewed as a critical component for achieving strategic priorities, with a focus on accessing new markets and expanding the product portfolio [9][41] Management's Comments on Operating Environment and Future Outlook - Management acknowledged potential impacts from supply chain disruptions but emphasized proactive measures to mitigate risks [6][31] - The company is increasing its revenue guidance for the full year to a range of $1.47 to $1.49 billion, driven by improved light vehicle production expectations [16] - The strategic footprint realignment is on track for completion by the end of next year, with anticipated savings and margin improvements expected to materialize in 2027 [9][40] Other Important Information - Gentherm's operational excellence initiatives are gaining traction, contributing to improved cash generation and efficiency [5][8] - The company is leveraging existing automotive intellectual property to accelerate new product development in the medical segment [8] Q&A Session Summary Question: Factors contributing to momentum in winning the conquest business with Mercedes-Benz - Management highlighted innovative edge, strong customer relationships, and value proposition as key factors [22][23] Question: Breakdown of the $300 million adjacent market opportunity - Management indicated that the pipeline is roughly a third for furniture, a third for commercial vehicles, and a third for other mobility, with furniture showing rapid adoption [25][26] Question: Near-term production environment and guidance - Management discussed ongoing supply chain issues but noted no significant impacts on Gentherm's schedules yet [31][34] Question: Potential opportunities in the Indian market - Management expressed interest in the Indian market due to its scale and potential for alternative revenue streams, particularly in two-wheelers [35][36] Question: Strategic footprint alignment plan and expected savings - Management indicated that savings from the footprint transitions will be more apparent in 2027, with some legacy costs falling off in 2026 [40][41]

Core Insights - HPE hosted its Securities Analyst Meeting at the New York Stock Exchange, where key executives discussed the company's strategic priorities and financial outlook through fiscal year 2028 [1] Group 1: Strategic Priorities - HPE's leadership position in the high-growth, high-margin networking market was emphasized as a key strategic priority [1] Group 2: Financial Outlook - The financial outlook presented by HPE executives indicates a focus on growth and profitability through fiscal year 2028 [1]

Core Insights - Cal-Maine Foods reported its strongest first quarter in company history, driven by higher specialty egg sales and the expansion of its prepared foods platform [3][4] - The company is positioned for growth through strategic priorities including expanding specialty eggs and prepared foods, pursuing disciplined M&A, and leveraging operational excellence [7][8] Financial Performance - Net sales reached $922.6 million, a 17.4% increase from $785.9 million in the previous year [4][27] - Gross profit increased by 25.9% to $311.3 million, with a gross profit margin of 33.7% [6][27] - Operating income rose 33.3% to $249.2 million, with an operating income margin of 27.0% [7][27] - Net income was $199.3 million, up 32.9%, translating to diluted earnings per share of $4.12, a 34.6% increase [7][27] Sales Breakdown - Shell egg sales accounted for $789.4 million, up 6.5%, while specialty egg sales increased by 10.4% to $283.5 million [4][5] - Prepared foods sales surged 839.1% to $83.9 million, significantly aided by the acquisition of Echo Lake Foods [4][9] - Specialty eggs and prepared foods combined represented 39.8% of net sales, up from 33.8% [7][9] Strategic Initiatives - The company is focusing on expanding its specialty egg offerings, which include cage-free, organic, and pasture-raised categories, to meet consumer demand [8][10] - Recent acquisitions, such as Echo Lake Foods, are aimed at enhancing product differentiation and expanding into new food formats [12][13] - Investments in operational capabilities, including a new high-speed pancake production line, are expected to enhance growth in the frozen breakfast category [14] Market Dynamics - U.S. egg consumption is driven by trends favoring protein-rich foods and health-conscious choices, with specialty eggs and prepared foods gaining market share [17] - The national table-egg flock is recovering from the impacts of Highly Pathogenic Avian Influenza (HPAI), but remains below historical levels, necessitating strong biosecurity measures [17] Future Outlook - The company anticipates a clear long-term growth trajectory, supported by its scale, vertical integration, and financial discipline [18] - Specialty eggs and prepared foods are expected to continue as key value drivers for the future [18]

Group 1 - Brookfield Asset Management held its 2025 Investor Day, emphasizing the importance of strategic priorities for sustained growth across its businesses [1][2] - The President, Connor Teskey, will discuss the company's strategic priorities that drive success [2] - CFO Hadley Peer Marshall will review the targets set five years ago, the company's performance against those targets, and outline plans for the next five years [2] Group 2 - A panel discussion is scheduled to highlight important strategies and rapidly scaling funds [2] - Executive Vice Chair Cyrus Madon will engage in a conversation with CEO Bruce Flatt about leadership and lessons learned that have contributed to Brookfield's success [3]

Financial Data and Key Metrics Changes - Total revenues for the second quarter were $334.3 million, a decline of 6.2% year over year, consistent with expectations [12] - Earnings per share for the quarter were $0.59, aligning with expectations [21] - Overall gross margins increased by 40 basis points sequentially to 27.1%, driven by an increase in Flex margins [21] - Operating margin for the second quarter was 4.5%, with an effective tax rate of 24.6%, slightly lower than expected due to favorable adjustments [23][24] Business Line Data and Key Metrics Changes - Flex revenues in technology and finance and accounting businesses improved slightly sequentially in Q2, while Direct Hire revenues faced challenges [12] - Flex revenues in the finance and accounting business, which represent about 6% of total revenues, declined 16.8% year over year but saw sequential growth for the first time in years [18] - Average bill rate in the technology business remained stable at approximately $90, while the finance and accounting average bill rate improved to about $54 [14][18] Market Data and Key Metrics Changes - The company operates in a demand-constrained environment, with clients maintaining significant backlogs of technology investments [4][5] - Job gains have been concentrated in sectors like healthcare, leisure, hospitality, and construction, while job creation outside these sectors has been minimal [5] - The demand for consulting-led offerings remains strong, contributing to overall technology top-line outperformance [13] Company Strategy and Development Direction - The company is focused on organic growth strategies and investing in consulting-oriented solutions to meet client needs [10][12] - There is a strategic shift towards providing flexible talent solutions as companies assess macroeconomic conditions [6][9] - The company aims to leverage AI and other innovative technologies to enhance business operations and client offerings [6][9] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the stability of the technology business and the potential for growth in AI-related services [9][20] - The company anticipates a modest sequential decline in technology business revenues in Q3 due to unexpected project ends [17] - Management highlighted the importance of retaining productive associates and making targeted investments to capitalize on future market demand [19][20] Other Important Information - The company has returned approximately $1 billion in capital to shareholders since 2007, representing about 75% of cash generated [26] - The company expects Q3 revenues to be in the range of $324 million to $332 million, with earnings per share between $0.53 and $0.61 [26] Q&A Session Summary Question: Can you discuss the levels of discussion regarding AI and when the company expects to assist clients more significantly? - Management noted that most organizations are still in the preparation phase for AI, focusing on foundational readiness aspects [30][31] Question: What is the nature of the unexpected project ends mentioned? - Management clarified that these project ends were due to clients reallocating technology investments rather than budget cuts [36][37] Question: How is the pipeline looking currently? - Management indicated that the pipeline remains strong, with pent-up demand for legacy projects and increased interest in data and AI preparation [38][39] Question: Is there a common thread among the project ends impacting trends? - Management stated that the project ends were largely due to strategic reallocations of technology investments by clients [77][80] Question: What impact does the nearshore/offshore dynamic have on margins? - Management confirmed that while the nearshore/offshore business is small, it has been slightly accretive to margins [81]